240 related articles for article (PubMed ID: 28803024)
21. Atypical phenotypes and novel OCRL variations in southern Chinese patients with Lowe syndrome.
Du R; Zhou C; Chen S; Li T; Lin Y; Xu A; Huang Y; Mei H; Huang X; Tan D; Zheng R; Liang C; Cai Y; Shao Y; Zhang W; Liu L; Zeng C
Pediatr Nephrol; 2024 Aug; 39(8):2377-2391. PubMed ID: 38589698
[TBL] [Abstract][Full Text] [Related]
22. Novel OCRL mutations in Chinese children with Lowe syndrome.
Zhang YQ; Wang F; Ding J; Yan H; Yang YL
World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333
[TBL] [Abstract][Full Text] [Related]
23. [Oculo-cerebro-renal Lowe syndrome: clinical, biochemical and molecular studies in a Moroccan patient].
Chabaâ L; Monnier N; Dahri S; Jorio M; Lunardi J; Chabraoui L
Ann Biol Clin (Paris); 2006; 64(1):53-9. PubMed ID: 16420990
[TBL] [Abstract][Full Text] [Related]
24. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.
Recker F; Zaniew M; Böckenhauer D; Miglietti N; Bökenkamp A; Moczulska A; Rogowska-Kalisz A; Laube G; Said-Conti V; Kasap-Demir B; Niemirska A; Litwin M; Siteń G; Chrzanowska KH; Krajewska-Walasek M; Sethi SK; Tasic V; Anglani F; Addis M; Wasilewska A; Szczepańska M; Pawlaczyk K; Sikora P; Ludwig M
Pediatr Nephrol; 2015 Jun; 30(6):931-43. PubMed ID: 25480730
[TBL] [Abstract][Full Text] [Related]
25. An in vitro splicing assay reveals the pathogenicity of a novel intronic variant in ATP6V0A4 for autosomal recessive distal renal tubular acidosis.
Yamamura T; Nozu K; Miyoshi Y; Nakanishi K; Fujimura J; Horinouchi T; Minamikawa S; Mori N; Fujimaru R; Nakanishi K; Ninchoji T; Kaito H; Mariko TI; Morioka I; Matsuo M; Iijima K
BMC Nephrol; 2017 Dec; 18(1):353. PubMed ID: 29202719
[TBL] [Abstract][Full Text] [Related]
26. Selective proximal renal tubular involvement and dyslipidemia in two cousins with oculocerebrorenal syndrome of Lowe.
Topaloğlu R; Ludwig M; Çelebi Tayfur A
Turk J Pediatr; 2013; 55(3):331-4. PubMed ID: 24217083
[TBL] [Abstract][Full Text] [Related]
27. Kidney Tubular Ablation of
Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
[TBL] [Abstract][Full Text] [Related]
28. A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
Sugimoto K; Nishi H; Miyazawa T; Fujita S; Okada M; Takemura T
Tohoku J Exp Med; 2014 Mar; 232(3):163-6. PubMed ID: 24614960
[TBL] [Abstract][Full Text] [Related]
29. Hypotonia and delayed motor development as an early presentation of Lowe syndrome: case report and literature review.
David S; De Waele K; De Wilde B; Faes F; Vanakker O; Walraedt S; Prytuła A
Acta Clin Belg; 2019 Dec; 74(6):460-464. PubMed ID: 30501482
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of the Lowe syndrome protein OCRL1.
Lowe M
Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
[TBL] [Abstract][Full Text] [Related]
31. Establishment of patient-specific induced pluripotent stem cell line SDUBMSi009-A from a patient with X-linked Lowe syndrome.
Liu X; Liu Y; Ma Y; Gong Y; Liu Q; Sun W; Guo H
Stem Cell Res; 2021 Mar; 51():102171. PubMed ID: 33540283
[TBL] [Abstract][Full Text] [Related]
32. Base editing correction of OCRL in Lowe syndrome: ABE-mediated functional rescue in patient-derived fibroblasts.
Chen S; Lo CH; Liu Z; Wang Q; Ning K; Li T; Sun Y
Hum Mol Genet; 2024 Jun; 33(13):1142-1151. PubMed ID: 38557732
[TBL] [Abstract][Full Text] [Related]
33. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.
Leahey AM; Charnas LR; Nussbaum RL
Hum Mol Genet; 1993 Apr; 2(4):461-3. PubMed ID: 8504307
[TBL] [Abstract][Full Text] [Related]
34. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
De Matteis MA; Staiano L; Emma F; Devuyst O
Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
[TBL] [Abstract][Full Text] [Related]
35. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
36. The oculocerebrorenal syndrome of Lowe: an update.
Bökenkamp A; Ludwig M
Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217
[TBL] [Abstract][Full Text] [Related]
37. Lowe syndrome - Case report with a novel mutation in the oculocerebrorenal gene.
Sethi S; Sethi N; Mehta S; Kaur S; Makkar V; Sohal PM
Saudi J Kidney Dis Transpl; 2020; 31(1):285-288. PubMed ID: 32129227
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations.
Liu H; Barnes J; Pedrosa E; Herman NS; Salas F; Wang P; Zheng D; Lachman HM
J Neurodev Disord; 2020 May; 12(1):14. PubMed ID: 32393163
[TBL] [Abstract][Full Text] [Related]
39. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature:
Gianesello L; Arroyo J; Del Prete D; Priante G; Ceol M; Harris PC; Lieske JC; Anglani F
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680992
[TBL] [Abstract][Full Text] [Related]
40. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
